HOME >> BIOLOGY >> NEWS
Lung cancer vaccine trial continues at UK's Markey Cancer Center

LEXINGTON, Ky. (April 5, 2005) - Two University of Kentucky researchers continue their work with a vaccine to prevent lung cancer recurrences in patients following primary treatment of the disease.

Vaccines are being developed with the hope of reducing the unacceptably high rates of recurrence and disease progression seen in the treated lung cancer population. The cancer vaccine program is now enrolling a second cohort of subjects to study the effects of the vaccine in lung cancer patients. The vaccine is delivered following conventional treatment with surgery, radiation therapy or chemotherapy and the patients evaluated for immune responses that could indicate clinical benefit.

Edward A. Hirschowitz, M.D., Associate professor of medicine, and John Yannelli, Ph.D., Associate professor of Microbiology and Immunology, both in the UK College of Medicine, are using white blood cells from the patients' blood to make the vaccine. They then administer the vaccine to the patient which allows the patient's immune system to recognize and destroy tumor cells that can lead to recurrences after cancer treatment.

"This trial is important in the fight against lung cancer because additional medical therapies are not generally recommended until recurrences are seen," said Hirschowitz. "We are using the window between definitive medical or surgical therapy and lung cancer recurrence to enhance the immune response to a cancer recurrence."

The vaccine in this study uses dendritic cells, the most potent immune inducing cells found in the human body. In the lab these cells can be grown in large numbers then programmed with tumor information that directs the immune system to recognize and kill tumor cells in the body.

"UK is in the forefront of cancer research and therapy with this study," said Yannelli. "Only in the past five years have scientists learned to grow these cells in large numbers and manipulate their biology in laboratory culture. As a re
'"/>

Contact: Louise DuPont
mldupo00@email.uky.edu
859-323-6363
University of Kentucky
5-Apr-2005


Page: 1 2

Related biology news :

1. Protein chatter linked to cancer activation
2. Newly created cancer stem cells could aid breast cancer research
3. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
4. ESF EURYI award winner aims to stop cancer cells reading their own DNA
5. No evidence that widely prescribed statins protect against prostate cancer
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. New study suggests Concord grape juice may provide protection against breast cancer
8. New test improves detection of liver cancer
9. High-intensity ultrasound may launch attack on cancer, wherever it lurks
10. Unknotting DNA clue to cancer syndrome
11. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/30/2019)... (PRWEB) , ... October 29, 2019 , ... ... calibration verification kits, for SIEMENS ATELLICA® analyzers, Order Numbers 701sa & 704sa. The ... NA, PHOS, UA, UTP, and UUN. , Each VALIDATE® kit, liquid, ready-to-use, and ...
(Date:10/30/2019)... ... October 30, 2019 , ... ... and bioactivity that are encoded by the ordering of monomer residues into ... shift of the sidechain attachment to the backbone amide-nitrogen atoms. They are ...
(Date:10/26/2019)... ... October 23, 2019 , ... ... Pico Automated Cell Imaging System including Digital Confocal 2D on-the-fly deconvolution, Live ... option allows scientists to decrease exposure time and improve the statistical significance ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... October 29, 2019 , ... Researchers ... Using Silios CMS-C multispectral imagers , researchers identified people by the image ... based on retinal imaging, face recognition, fingerprints and vasculature. , The new ...
(Date:10/22/2019)... ... October 22, 2019 , ... Enplug , ... Mass Notification System into its digital signage platform. The collaboration brings one of ... possible for users to leverage their existing digital signage networks to quickly disseminate ...
(Date:10/15/2019)... ... , ... ARPR , an award-winning tech PR agency at the epicenter of the future ... Agency of the Year in the Ragan’s Health Care PR & Marketing Awards. This award ... firm also revealed today that its healthIT practice group grew by 18 percent in Q3 ...
(Date:10/10/2019)... SCOTTSDALE, Ariz. (PRWEB) , ... October 10, 2019 ... ... Pratia , the largest network of clinical research centers in Europe. All ... first site network in Europe to become trained and certified as Virtual Trial ...
Breaking Biology Technology:
Cached News: